Princeton Junction, NJ, United States of America

Chenkou Wei

USPTO Granted Patents = 18 (Patent Applications = 5)

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 6 (Patent Applications = 11)

Average Co-Inventor Count = 4.3

ph-index = 5

Forward Citations = 110(Granted Patents)

Location History:

Princeton, NJ (US) (2012 - 2014)
Princeton Junction, NJ (US) (2000 - 2018)

Company Filing History:

15 out of 3,681

Bristol-myers Squibb Compnay

Years Active: 2000-2018

Loading Chart...

18 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 9920034 - Crystalline forms of a factor XIa inhibitor (2018-03-20),

2. 9173879 - Crystalline forms of (S)-7-([1,2,4]triazolo[1,5-a ]pyridin-6-yl)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydroisoquinoline and use thereof (2015-11-03),

3. 8901106 - Imidazole prodrug LXR modulators (2014-12-02),

4. 8815894 - [object Object] (2014-08-26),

5. 8802715 - Crystal forms of saxagliptin and processes for preparing same (2014-08-12),

6. 8759372 - [object Object] (2014-06-24),

7. 8691981 - Crystalline forms of (S)-1-(4-(5-cyclopropyl-1H-pyrazol-3-ylamino)pyrrolo[1,2-f][1,2,4]triazin-2-yl)-N-(6-fluoropyridin-3-yl)-2-methylpyrrolidine-2-carboxamide (2014-04-08),

8. 8541444 - Triazolopyridine 11-beta hydroxysteroid dehydrogenase type I inhibitors (2013-09-24),

9. 8236847 - Crystal forms of saxagliptin and processes for preparing same (2012-08-07),

10. 8119658 - Triazolopyridine 11-beta hydroxysteroid dehydrogenase type I inhibitors (2012-02-21),

11. 8063208 - Crystalline forms of (3R,4R)-4-amino-1-[[4-[(3-methoxyphenyl)amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]methyl]piperidin-3-ol (2011-11-22),

12. 7943656 - Crystal forms of saxagliptin and processes for preparing same (2011-05-17),

13. 7829711 - Crystalline materials of 1-(4-benzoyl-piperazin-1-yl)-2-[4-methoxy-7-(3-methyl-[1,2,4]triazol-1-yl)-1H-pyrrolo[2,3-C]pyridine-3-yl]-ethane-1,2-dione (2010-11-09),

14. 7381737 - Crystalline forms and process for preparing spiro-hydantoin compounds (2008-06-03),

15. 7008959 - Form of irbesartan, processes for obtaining the said and pharmaceutical compositions containing it (2006-03-07),

Title: Innovations and Contributions of Chenkou Wei

Introduction

Chenkou Wei is a prominent inventor based in Princeton Junction, NJ (US). He holds an impressive portfolio of 18 patents, showcasing his significant contributions to the field of pharmaceutical sciences. His work primarily focuses on developing innovative compounds for treating various medical conditions.

Latest Patents

Among his latest patents, Wei has developed crystalline forms of a factor XIa inhibitor. This invention provides crystalline forms of (S,E)-4-(2-(3-(3-chloro-2-fluoro-6-(1H-tetrazol-1-yl)phenyl)acryloyl)-5-(4-methyl-2-oxopiperazin-1-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid and its solvates. The patent also details processes for producing these crystalline forms, pharmaceutical compositions that include them, and methods for treating thromboembolic disorders using these compositions. Another notable patent involves crystalline forms of (S)-7-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydroisoquinoline. This invention describes novel compounds used in treating various neurological and physiological disorders.

Career Highlights

Chenkou Wei has had a distinguished career, working with leading pharmaceutical companies such as Bristol-Myers Squibb Company and Sanofi-Synthelabo. His expertise in drug development and innovation has made a significant impact in the pharmaceutical industry.

Collaborations

Throughout his career, Wei has collaborated with notable professionals, including Jack Z Gougoutas and Mary F Malley. These collaborations have contributed to the advancement of his research and the successful development of his patented inventions.

Conclusion

Chenkou Wei's innovative work and numerous patents reflect his dedication to advancing pharmaceutical science. His contributions continue to play a vital role in developing treatments for various medical conditions.

This text is generated by artificial intelligence and may not be accurate.